Chronic occupational metallic mercurialism;Mercuralismo metálico crônico ocupacional

Revista de Saude Publica

Volumn 37, Issue 1, 2003, Pages 116-127

  de Araújo Medrado Faria, Marcília ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Immunotoxicology; Mercury poisoning, prevention; Nephrotoxicology; Neuropsychological tests; Neurotoxicology; Occupational exposure

Indexed keywords

GOLD; MERCURY;

AMNESIA; APATHY; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC TOXICITY; DELIRIUM; DENTISTRY; DEPRESSION; HEADACHE; HUMAN; HYPERSENSITIVITY; HYPERTENSION; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INSOMNIA; IRRITABILITY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MEDICAL TECHNOLOGY; MEDLINE; MERCURIALISM; MINING; NEUROPSYCHOLOGY; OCCUPATIONAL ALLERGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PAIN; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PREVENTIVE HEALTH SERVICE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SELF CONCEPT; TREMOR; WORK ENVIRONMENT;

EID: 0037316740     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102003000100017     Document Type: Review

References (83)

1. Aguado S, Queiroz IF de, Marin R, Gago E, Gómez E, Fernandez-Veja F, Alvarez-Grande VJ. Acute mercury vapor intoxication. Nephrol Dial Transplant 1989;4:133-6.
2. Albers JW, Cavander GD, Levine SP, Langolf GD. Asymptomatic sensorimotor polyneuropathy in workers exposed to elemental mercury. Neurology 1982;32:1168-74.
3. Anderson A, Ellingsen DG, Morland T, Kjuus H. A neurological and neurophysiological study of chloralkali workers previously exposed to mercury vapour. Acta Neurol Scand 1993;88:427-33.
4. Angotzi GN, Battistini F, Garbonci F, Ciono R. Impairment of nervous system in workers exposed to inorganic mercury. Toxicol Eur Res 1981;3:275-8.
5. Asano S, Eto K, Kurisaki E, Gunji H, Hiraina K, Sato M et al. Review article: acute inorganic mercury vapour inhalation poisoning. Pathol Int 2000;50:169-74.
6. Assennato G, Porro A, Longo G, Longo F, Ambrosi. Valutazione degli effetti sul sistema nervoso dell'esposizione a basse concentrazioni di mercurio in addetti alla fabbricazione di lampade fluorescenti. L Med Lav 1989;80:307-15.
7. Barregård L, Enestrom S, Ljunghusen O, Wieslander J, Hultman P. A study of autoantibodies and circulating immune complexes in mercury-exposed chloralkali workers. Int Arch Occup Environ Health 1997;70:101-6.
8. Battigelli MC. Mercury. In: Rom WN, editor. Environmental and occupational medicine. Boston: Little, Brown & Co; 1983. p. 449-63.
9. Bencko V, Wagner V, Wagnerova M, Ondrejcak V. Immunological profiles in workers occupationally exposed to inorganic mercury. J Hyg Epidemiol Microbiol Immunol 1990;34:9-15.
10. Bigazzi PE. Autoimmunity induced by chemicals. Clin Toxicol 1988;26:126-56.
11. Bola KI. Neuropsychological evaluation for detecting alterations in the nervous system after chemical exposure. Regul Toxicol Pharmacol 1966;24:48-51.
12. Branches FJP, Erickson TB, Aks SE, Hryhorczuk DO. The price of gold: mercury exposure in the Amazonian rain forest. Clin Toxicol 1993;31:295-306.
13. Buchet JP, Roels H, Bernard A, Lauwerys R. Assessment of renal function of workers exposed to inorganic lead, cadmium or mercury vapor. J Occup Med 1988;22:741-50.
14. Capellaro E, Bonzanino A, Toscano G. Investigation of subjects exposed to mercury nitrate. Arch Sci Med 1980;137:515-24.
15. Cassito MG. Hänninen HO, Anger WK. Advances in neurobehavioral toxicology. Chelsea: Lewis Publishers; 1990.
16. Cavalleri A, Gobba F. Reversible color vision loss in occupational exposure to metallic mercury. Environ Res 1998;77:173-7.
17. Cavanagh JB. Long term persistence of mercury in the brain. Br J Ind Med 1988;45:649-51.
18. [CETESB] Companhia de Tecnologia de Saneamento Ambiental. Relatório técnico CETESB: Sistema Estuarino de Santos e São Vicente 2001. São Paulo; 2001.
19. Dantas DC, Queiroz ML. Immunoglobulin E and autoantibodies in mercury-exposed workers. Immunopharmacol Immunotoxicol 1997;19:383-92.
20. Davis LE, Kornfeld M, Moorey HS, Fiedler KJ, Haaland KY, Orrison WW et al. Methylmercury poisoning: long term clinical, radiological, toxicological and pathological studies of an affected family. Ann Neurol 1994;35:680-8.
21. Desoille H, Scherrer J, Thruhaut R. Mercure in précis de médicine du travail. Paris: Masson; 1975. Chap. 11. p. 908-10.
22. Drayer BP, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. Magnetic resonance imaging of brain iron. AJR Am J Roentegenol 1986;147:103-10
23. Ellingsen DG, Gaarder PI, Kjuus H. An immunological study of chloralkali workers previously exposed to mercury vapour. APMIS 1994;102:170-6.
24. Eto K. Tazikawa Y, Akagi H, Haraguchi K, Asano S, Takahata N, Jokunaga H. Differencial diagnosis between organic and inorganic mercury poisoning in human cases: the pathologic point of view. Toxicol Pathol 1999;27:664-71.
25. Foa V. Caimi L, Amante L, Antonini C, Gattinoni A, Tettamanti G et al. Patterns of some lysosomal enzymes in the plasma and of proteins in the urine of workers exposed to inorganic mercury. Int Arch Occup Environ Health 1976;37:115-24.
26. Freeman TW, Oppold JÁ. Mercury hazard and its control during operation of fluorescent tube breakers. Am Ind Hyg Assoc J 1972;27:419-22.
27. Frumkin H. Manning CC, Willians PL, Sanders A, Taylor BB, Pierce M et al. Diagnostic chelation challenge with DMSA: A biomarker of long-term mercury exposure? Environ Health Perspect 2001;109:167-71.
28. Friberg L, Hammarstrom S, Nystrom A. Kidney injury after chronic exposure to inorganic mercury. Arch Ind Hyg 1953;8:149-53.
29. Fuortes LJ, Weisman DN, Graeff ML, Bale Jr JF, Tannors R, Peters C. Immune thrombocytopenia and elemental mercury poisoning. J Toxicol Clin Toxicol 1995;33:449-55.
30. Gonzalez-Ramirez D, Zuniga-Charles M, Narro-Juarez A, Molina-Recio Y, Hurlbut KM, Dart RC, Aposhian HV. DMPS (2,3-Dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther 1988;287:8-12.
31. Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P. Sodium 2,3-dimercatopropane 1-sulfonate challenge test for mercury in humans. II. Urinary mercury, porphyins and neurobehavioral changes of dental workers in Monterrey, Mexico. J Pharm Exp Ther 1995;272:264-74.
32. Hänninen H. Behavioral effects of occupational exposure to mercury and lead. Acta Neurol Scand Suppl 1982;92:167-75.
33. Hargreaves RJ, Evans JG, Janota I, Magos L, Cavanagh JB. Persistent mercury in nerve cells 16 years after metallic mercury poisoning. Neuropathol Appl Neurobiol 1988;14:443-52.
34. Harrison DJ, Thomson D, MacDonald MK. Membranous glomerulonephritis. J Clin Pathol 1986;39:167-7.
35. Mantz JM. Acute accidental mercury vapor intoxication. Intensive Care Med 1979;5:205.
36. Kark RAP. Clinical and neurochemical aspects of inorganic mercury intoxication. In: Vinken PJ, Bruyn GW, de Wolff FA, editors. Intoxications of the nervous system: Part I. Amsterdan:Elsevier Science; 1994. Chap. 25. (Handbook of Clinical Neurology, 20).
37. Kazantzis G, Schiller KFR, Asscher AW, Drew RG. Albuminuria and the nephrotic symdrome following exposure to mercury and its compounds. QJ Med 1962;31:403-18.
38. Kishi R, Doi R, Fukuchi Y, Satoh T, Ono A, Moriwaka F et al. Subjective symptoms and neurobehavioral performances of ex mercury miners at an average of 18 years after the cessation of chronic exposure to mercury vapor. Environ Res 1993;62:289-302.
39. Kosta L, Byrne AR, Zelenko V. Correlation between selenium and mercury in man following to inorganic mercury. Nature 1975;254:238-9.
40. Langauer LH, Kurzbauer H, Zajac NM. Value of electroencephalographic studies for the evaluation of the neurotoxic effect of metallic mercury. Neurol Neurochir Pol 1988;22:489-94.
41. Langolf GD, Chaffin DB, Henderson R, Whittle HP. Evaluation of workers exposed to elemental mercury using quantitative tests of tremor and neuromuscular functions. Ann Occup Hyg 1981;24:293-6.
42. Lauwerys RR. Toxicologie industrielle et intoxications profissionnelles. Paris: Masson; 1992. Le mercure.
43. Lille F, Hazemann P, Garnier R, Ally S. Effects of lead and mercury intoxication on evoked potentials. J Toxicol Clin Toxicol 1988;26:103-16.
44. Matheson DS, Clarkson TW, Gelfand EW. Mercury toxicity (acrodynia) induced by longterm injection of gammaglobulin. J Pediatr 1980;97:153-5.
45. Mazeyrat A. A propos du Mercure [These de doctoral]. Paris: Université Pierre et Marie Curie; 1985.
46. McFarland RB, Reigel H. Chronic mercury poisoning from a single brief exposure. J Occup Med 1978;20:532-4.
47. Michaelson JH, McCoy JP, Hirszel P, Bigazzi PE. Mercury induced autoimmune glomerulonephritis imbred rats. I kinetics and species specificitu of autoimmune responses. SURV Synth Pathol Res 1985;4:401-11.
48. Ministério da Previdência Social. Decreto no. 3.048 que discrimina dezessete doenças causadas pelo mercúrio. Diário Oficial da União, Brasília (DF), 12 maio 1999.
49. a edição. São Paulo, Ed. Atlas, 2001. (NR 07anexo 1: 95 e NR 15 anexo11: 1999.)
50. Morgan D. Assessment of renal tubular function and damage and their clinical significance Ann Clin Biochem 1982;19:307-13.
51. Moszczynski P, Lisiewicz J, Bartus R, Bem S. The serum immunoglobulins in workers after prolonged occupational exposure to the mercury vapors. Med Interne 1990;28:25-30.
52. Nadorfy-Lopez E, Torres SH, Finol H, Mendez M, Bello B. Skeletal muscle abnormalities associated with occupacional exposure to mercury vapours. Histol Histopathol 2000;15:673-82.
53. Neal PA, Jones PR. Chronic mercuralism in the hatter's furcutting industry. J Am Wom Assoc 1938;110:337-43.
54. Ngim CD, Foo SC, Boey KW, Jeyaratnam J. Chronic neurobehavioral effects of elemental mercury dentists. Br J Ind Med 1992;49:782-90.
55. Nylander M, Friberg I, Lind B. Mercury concentration in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed Dent J 1987;11:179-87.
56. O'Carrol RE, Masterton G, Dougall N, Ebmeier KP, Goodwin GM. The neuropsychiatric sequelae of mercury poisoning. The Mad Hatter's disease revisited. Br J Psychiatry 1995;167:95-8.
57. Oliveira JJ, Silva SR. Hipertensão arterial secundária a intoxicação por mercúrio com síndrome clínicolaboratorial simulando feocromocitoma. Arq Bras Cardiol 1996;66:29-31.
58. Opitz H, Schweinsberg F, Grossmann T, Wendt-Gallitelli MF, Meyermann R. Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure. Clin Neuropathol 1996;15:139-44.
59. Piikivi L, Tolonen U. EEG findings in Chlor-alkali workers subjected to low long term exposure to mercury vapour. Br J Ind Med 1989;46:370-5.
60. Piikivi L, Hänninen H. Subjects symtoms and psychological performance of chlororine alkali workers. Scand J Work Environ Health 1989;15:69-74.
61. Powell TJ. Chronic neurobehavioral effects of mercury poisoning on a group of Zulu chemical workers. Brain Inj 2000; 14(9):797-814.
62. Queiroz ML, Perligeiro RC, Dantas DC, Bizzacchi JM, De-Capitani EM. Immunoglobulin levels in workers exposed to inorganic mercury. Pharmacol Toxicol 1994;74:72-5.
63. Queiroz ML, Dantas DC. T lymphocytes in mercury-exposed workers. Immunopharmacol Immunotoxicol 1997;19:499-510.
64. Roels H, Abdeladim S, Braun M, Malchaire J, Lauwerys R. Detection od hand tremor in workers exposed to mercury vapor. Environ Res 1989;49:152-65.
65. Rossini SRG, Reimão R, Lefèvre BH, Medrado-Faria MA. Chronic insomnia in workers poisoned by inorganic mercury. Arq Neuropsiquiatr 2000;58:33-8.
66. Satoh H. Occupational and environmental toxicology of mercury and its compounds. Ind Health 2000;38:153-64.
67. Shapiro IM, Cornflath DR, Sumner AJ, Uzzell B, Spitz LK, Ship II, Bloch P. Neurophysiological and neuropsychological function in mercury exposed dentists. Lancet 1982;1(8282):1147-50.
68. Smetana S, Khalef S, Zaidel L, Bar-Khayim Y, Birk-Y. Increased urinary trypsin-inhibitory activity in mercury chloride induced nephrotoxicity in Wistar rats. Ren Fail 1996;18:201-9.
69. Smith PJ, Langolf GD, Goldberg J. Effects of occupational exposure to elemental mercury on short term memory. Br J Ind Med 1983;40:413-9.
70. Soleo L, Vacca A, Vimercati L, Bruno S, Di Loreto M, Zocchetti C et al. Minimal immunological effects on workers with prolonged low exposure to inorganic mercury. Occup Environ Med 1997;54:437-42.
71. Soleo L, Urbano MI, Petrava V, Ambresi L. Effects of low exposure to inorganic mercury on psychological performance. Br J In Med 1990;47:105-9.
72. Solis MT, Yuen E, Cortez PS, Goebel PJ. Family poisoned by mercury vapor inhalation. Am J Emerg Med 2000;18:599-602.
73. Sorensen FW, Larsen JO, Eide R, Schionning JD. Neuron loss in cerebellar cortex of rats exposed to mercury vapor: a stereological study. Acta Neuropathol 2000;100:95-100.
74. Tilson HA. Neurobehavioral methods used in neurotoxicological research. Toxicol Lett 1993;68:231-40.
75. Tubbs RR, Gephardt GN, McMahon JT, Pohl MC, Vidt DG, Barenberg SA, Valenzuela R. Membranous glomerulonephritis associated with industrial mercury exposure: Study of pathogenetic mechanisms. Am J Clin Pathol 1982;77:409-13.
76. Uchino M, Okajima T. Eto K, Kumamoto T, Mishima I, Ando M. Neurologic features of chronic disease (organic mercury poisoning) certified at autopsy. Intern Med 1995;34:744-7.
77. Vroom FQ, Greer M. Mercury vapour intoxication. Brain 1972;95:305-18.
78. [WHO] World Health Organization. Mercury. Geneva; 1976. (Environmental Health Criteria, 1).
79. [WHO] World Health Organization. Recommended health-based limits in occupational exposure to heavy metals. Geneva; 1980. (WHO - Technical Report Series, 647).
80. [WHO] World Health Organization. Methylmercury. Geneva; 1990. (Environmentaql Health Criteria, 101).
81. [WHO] World Health Organization. Inorganic Mercury. Geneva; 1991. (Environmental Health Criteria, 118).
82. Zeglio P. Long- term effects of mercuralism. Lav Um 1958;10:420-2.
83. Zavariz C, Glina DMR. Efeitos da exposição ocupacional ao mercúrio, em trabalhadores de uma indústria de lâmpadas elétricas localizada em Santo Amaro, Brasil. Cad Saúde Pública 1993;9:117-29.